AAAAAA
Results:
1-21
|
Results: 21
Authors:
GISSELBRECHT C
HAIOUN C
LEPAGE E
BASTION Y
TILLY H
BOSLY A
DUPRIEZ B
MARIT G
HERBRECHT R
DECONINCK E
MAROLLEAU JP
YVER A
DABOUZHARROUCHE F
COIFFIER B
REYES F
Citation: C. Gisselbrecht et al., PLACEBO-CONTROLLED PHASE-III STUDY OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA - FACTORS INFLUENCING CHEMOTHERAPY ADMINISTRATION, Leukemia & lymphoma, 25(3-4), 1997, pp. 289-300
Authors:
HOGLUND M
SMEDMYR B
BENGTSSON M
TOTTERMAN TH
COURCHABERNAUD V
YVER A
SIMONSSON B
Citation: M. Hoglund et al., MOBILIZATION OF CD34(-CSF IN HEALTHY-VOLUNTEERS - A COMPARATIVE-STUDY() CELLS BY GLYCOSYLATED AND NONGLYCOSYLATED G), European journal of haematology, 59(3), 1997, pp. 177-183
Authors:
GAJEWSKI J
WALL D
ADKINS D
GELLER R
YVER A
LLOYD K
SOUZA S
CHAMPLIN R
Citation: J. Gajewski et al., A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED BONE-MARROW TRANSPLANT/, Experimental hematology, 25(8), 1997, pp. 292-292
Authors:
GAJEWSKI J
WALL D
ADKINS D
GELLER R
YVER A
LLOYD K
SOUZA S
CHAMPLIN R
Citation: J. Gajewski et al., A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION WITH CD5 8 COLLECTOR(R) IN ADDITION TO CYCLOSPORINE, METHOTREXATE AND STEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE PREVENTION IN HLA MISMATCHED OR UNRELATED BONE-MARROW TRANSPLANT/, Blood, 90(10), 1997, pp. 4527-4527
Authors:
GAJEWSKI J
WALL D
ADKINS D
GELLER R
YVER A
LLOYD K
SOUZA S
CHAMPLIN R
Citation: J. Gajewski et al., A RANDOMIZED DOUBLE-BLIND TRIAL OF T-CELL DEPLETION (TCD) WITH CD5 8 CELLECTOR(R) IN ADDITION TO CYCLOSPORINE (CSA), METHOTREXATE (MTX) ANDSTEROIDS FOR ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PREVENTION IN HLA MISMATCHED (MM) BONE MARRROW TRANSPLANTS (BMT)/, Blood, 88(10), 1996, pp. 1002-1002
Authors:
SEYMOUR AM
DECAMPOS E
THATCHER N
DEGREVE J
CUNNINGHAM D
HOWELL A
TUENI E
BRON DG
STEWARD WP
BERDEL WE
KNUTH A
LORENZ J
TIMOTHY AR
YVER A
RICHARDS MA
Citation: Am. Seymour et al., A SINGLE-BLIND, RANDOMIZED, VEHICLE-CONTROLLED DOSE-FINDING STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (LENOGRASTIM) IN PATIENTS UNDERGOING CHEMOTHERAPY FOR SOLID CANCERS AND LYMPHOMA, European journal of cancer, 31A(13-14), 1995, pp. 2157-2163
Authors:
CHEVALLIER B
CHOLLET P
MERROUCHE Y
ROCHE H
FUMOLEAU P
KERBRAT P
GENOT Y
FARGEOT P
OLIVIER JP
FIZAMES C
CLAVEL M
YVER A
CHABERNAUD VC
Citation: B. Chevallier et al., LENOGRASTIM PREVENTS MORBIDITY FROM INTENSIVE INDUCTION CHEMOTHERAPY IN THE TREATMENT OF INFLAMMATORY BREAST-CANCER, Journal of clinical oncology, 13(7), 1995, pp. 1564-1571
Authors:
DOMBRET H
CHASTANG C
FENAUX P
REIFFERS J
BORDESSOULE D
BOUABDALLAH R
MANDELLI F
FERRANT A
AUZANNEAU G
TILLY H
YVER A
DEGOS L
Citation: H. Dombret et al., A CONTROLLED-STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS AFTER TREATMENT FOR ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(25), 1995, pp. 1678-1683
Authors:
FOSSAT C
STOPPA AM
SAINTY D
BLAISE D
VIENS P
BAYSSAS M
YVER A
JUHANVAGUE I
MARANINCHI D
Citation: C. Fossat et al., IN-VIVO STIMULATION OF NEUTROPHIL FUNCTION BY LENOGRASTIM (GLYCOSYLATED RHUG-CSF) IN ONCOHEMATOLOGIC PATIENTS - RESULTS OF A PHASE-I TRIAL, Stem cells, 12(3), 1994, pp. 322-328
Authors:
CLEARY PD
MORRISSEY G
YVER A
OSTER G
Citation: Pd. Cleary et al., THE EFFECTS OF RG-CSF ON HEALTH-RELATED QUALITY-OF-LIFE IN CHILDREN WITH CONGENITAL AGRANULOCYTOSIS, Quality of life research, 3(5), 1994, pp. 307-315
Authors:
STOPPA AM
BLAISE D
VIENS P
BAUME D
MANNONI P
NOVAKOVITCH G
DAVID FA
YVER A
MARANINCHI D
Citation: Am. Stoppa et al., PHASE-I STUDY OF IN-VIVO LENOGRASTIM (RHUG-CSF) FOR STEM-CELL COLLECTION DEMONSTRATES IMPROVED NEUTROPHIL RECOVERY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 13(5), 1994, pp. 541-547
Authors:
BASTION Y
REYES F
BOSLY A
GISSELBRECHT C
YVER A
GILLES E
MARAL J
COIFFIER B
Citation: Y. Bastion et al., POSSIBLE TOXICITY WITH THE ASSOCIATION OF G-CSF AND BLEOMYCIN, Lancet, 343(8907), 1994, pp. 1221-1222
Authors:
GISSELBRECHT C
PRENTICE HG
BACIGALUPO A
BIRON P
MILPIED N
RUBIE H
CUNNINGHAM D
LEGROS M
PICO JL
LINCH DC
BURNETT AK
SCARFFE JH
SIEGERT W
YVER A
Citation: C. Gisselbrecht et al., PLACEBO-CONTROLLED PHASE-III TRIAL OF LENOGRASTIM IN BONE-MARROW TRANSPLANTATION, Lancet, 343(8899), 1994, pp. 696-700
Authors:
DONADIEU J
BOUTARD P
TCHERNIA G
OSTER G
GORDONSMITH EC
PHILIPPE N
LEGALL E
NIVELON JL
DOPFER R
BABINBOILLETOT A
COULOMBEL L
POCIDALO MA
YVER A
GRISCELLI C
Citation: J. Donadieu et al., A PHASE-II STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHUG-CSF, LENOGRASTIM) IN THE TREATMENT OF AGRANULOCYTOSIS IN CHILDREN, Nouvelle revue francaise d'hematologie, 36(6), 1994, pp. 441-448
Authors:
GISSELBRECHT C
BASTION Y
HAIOUN C
LEPAGE E
TILLY H
BOSLY A
DUPRIEZ B
MARIT G
DECONINCK E
MAROLLEAU JP
YVER A
COIFFIER B
REYES F
Citation: C. Gisselbrecht et al., PLACEBO-CONTROLLED PHASE-III TRIAL OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN G-CSF) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL), Blood, 84(10), 1994, pp. 10000167-10000167
Authors:
DOMBRET H
YVER A
CHASTANG C
DEGOS L
Citation: H. Dombret et al., INCREASED FREQUENCY OF COMPLETE REMISSION BY LENOGRASTIM RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) ADMINISTRATION AFTER INTENSIVE INDUCTION CHEMOTHERAPY IN ELDERLY PATIENTS WITH DE-NOVOACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A RANDOMIZED MULTICENTER DOUBLE-BLIND CONTROLLED-STUDY, Blood, 84(10), 1994, pp. 10000231-10000231
Authors:
REY C
BADERMEUNIER B
TERTIAN G
MIELOT F
TCHERNIA G
YVER A
Citation: C. Rey et al., TRILINEAGE RESPONSE TO RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ADMINISTRATION IN A PATIENT WITH MYELODYSPLASTIC SYNDROME, American journal of hematology, 43(1), 1993, pp. 76-77
Authors:
LINCH DC
SCARFFE H
PROCTOR S
CHOPRA R
TAYLOR PRA
MORGENSTERN G
CUNNINGHAM D
BURNETT AK
CAWLEY JC
FRANKLIN IM
BELL AJ
LISTER TA
MARCUS RE
NEWLAND AC
PARKER AC
YVER A
Citation: Dc. Linch et al., RANDOMIZED VEHICLE-CONTROLLED DOSE-FINDING STUDY OF GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 11(4), 1993, pp. 307-311
Authors:
DONADIEU J
BADERMEUNIER B
BERTRAND Y
LACHAUX A
LABRUNE P
GOUGEROTPOCIDALO MA
ODIEVRE M
GIBEAUD P
YVER A
TCHERNIA G
GRISCELLI C
DOMMERGUES JP
Citation: J. Donadieu et al., RECOMBINANT HUMAN G-CSF (LENOGRASTIM) FOR INFECTIOUS COMPLICATIONS INGLYCOGEN-STORAGE-DISEASE TYPE-IB - REPORT OF 7 CASES, Nouvelle revue francaise d'hematologie, 35(6), 1993, pp. 529-534
Authors:
GISSELBRECHT C
PRENTICE G
BACIGALUPO A
BIRON P
MILPIED N
RUBIE H
CUNNINGHAM D
LEGROS M
PICO JL
LINCH DC
BURNETT AK
SCARFFE JH
SIEGERT W
YVER A
Citation: C. Gisselbrecht et al., A PHASE-III RANDOMIZED PLACEBO-CONTROLED STUDY IN 315 PEDIATRIC AND ADULT AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH LENOGRASTIM-5 UG KG/DAY (GLYCOSYLATED RHU-G-CSF)/, Blood, 82(10), 1993, pp. 10000455-10000455
Authors:
HOGLUND M
LOFVENBERG E
SIMONSSON B
SMEDMYR B
WAHLIN A
YVER A
Citation: M. Hoglund et al., PHARMACOKINETICS OF GLYCOSYLATED RHUG-CSF (LENOGRASTIM) IN PATIENTS TREATED WITH CHEMOTHERAPY PLUS-OR-MINUS ABMT, Blood, 82(10), 1993, pp. 10000500-10000500
Risultati:
1-21
|